Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021

• Egile Nagusiak: Lisa Clemans-Cope (Egilea), Victoria Lynch (Egilea), Maya Payton (Egilea), Joshua Aarons (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background As Medicaid is the largest payer for opioid use disorder (OUD) treatment services in the United States, information about Medicaid provider reimbursement is critical, and Medicaid payment policies influence the structure of OUD treatment services for everyone with OUD treatment n...